Global Drugs for Irritable Bowel Syndrome Supply, Demand and Key Producers, 2023-2029
The global Drugs for Irritable Bowel Syndrome market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Drugs for Irritable Bowel Syndrome demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drugs for Irritable Bowel Syndrome, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drugs for Irritable Bowel Syndrome that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drugs for Irritable Bowel Syndrome total market, 2018-2029, (USD Million)
Global Drugs for Irritable Bowel Syndrome total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Drugs for Irritable Bowel Syndrome total market, key domestic companies and share, (USD Million)
Global Drugs for Irritable Bowel Syndrome revenue by player and market share 2018-2023, (USD Million)
Global Drugs for Irritable Bowel Syndrome total market by Type, CAGR, 2018-2029, (USD Million)
Global Drugs for Irritable Bowel Syndrome total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Drugs for Irritable Bowel Syndrome market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceutical Company Limited, Pfizer, Inc., Abbott Laboratories, Novartis AG, AstraZeneca PLC, Ironwood Pharmaceuticals Inc. and Allergan Plc, Bausch Health Companies Inc., GlaxoSmithKline, Plc. and Lexicon Pharmaceuticals, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drugs for Irritable Bowel Syndrome market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Drugs for Irritable Bowel Syndrome Market, By Region:
1. How big is the global Drugs for Irritable Bowel Syndrome market?
2. What is the demand of the global Drugs for Irritable Bowel Syndrome market?
3. What is the year over year growth of the global Drugs for Irritable Bowel Syndrome market?
4. What is the total value of the global Drugs for Irritable Bowel Syndrome market?
5. Who are the major players in the global Drugs for Irritable Bowel Syndrome market?
6. What are the growth factors driving the market demand?
This report studies the global Drugs for Irritable Bowel Syndrome demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drugs for Irritable Bowel Syndrome, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drugs for Irritable Bowel Syndrome that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drugs for Irritable Bowel Syndrome total market, 2018-2029, (USD Million)
Global Drugs for Irritable Bowel Syndrome total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Drugs for Irritable Bowel Syndrome total market, key domestic companies and share, (USD Million)
Global Drugs for Irritable Bowel Syndrome revenue by player and market share 2018-2023, (USD Million)
Global Drugs for Irritable Bowel Syndrome total market by Type, CAGR, 2018-2029, (USD Million)
Global Drugs for Irritable Bowel Syndrome total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Drugs for Irritable Bowel Syndrome market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceutical Company Limited, Pfizer, Inc., Abbott Laboratories, Novartis AG, AstraZeneca PLC, Ironwood Pharmaceuticals Inc. and Allergan Plc, Bausch Health Companies Inc., GlaxoSmithKline, Plc. and Lexicon Pharmaceuticals, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drugs for Irritable Bowel Syndrome market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Drugs for Irritable Bowel Syndrome Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Alosetron
- Lubiprostone
- Linaclotide
- Others
- Hospital
- Clinic
- Others
- Takeda Pharmaceutical Company Limited
- Pfizer, Inc.
- Abbott Laboratories
- Novartis AG
- AstraZeneca PLC
- Ironwood Pharmaceuticals Inc. and Allergan Plc
- Bausch Health Companies Inc.
- GlaxoSmithKline, Plc.
- Lexicon Pharmaceuticals, Inc.
- Sucampo Pharmaceuticals, Inc.
1. How big is the global Drugs for Irritable Bowel Syndrome market?
2. What is the demand of the global Drugs for Irritable Bowel Syndrome market?
3. What is the year over year growth of the global Drugs for Irritable Bowel Syndrome market?
4. What is the total value of the global Drugs for Irritable Bowel Syndrome market?
5. Who are the major players in the global Drugs for Irritable Bowel Syndrome market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Drugs for Irritable Bowel Syndrome Introduction
1.2 World Drugs for Irritable Bowel Syndrome Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Drugs for Irritable Bowel Syndrome Total Market by Region (by Headquarter Location)
1.3.1 World Drugs for Irritable Bowel Syndrome Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.3.3 China Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.3.4 Europe Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.3.5 Japan Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.3.6 South Korea Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.3.7 ASEAN Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.3.8 India Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drugs for Irritable Bowel Syndrome Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drugs for Irritable Bowel Syndrome Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.2 World Drugs for Irritable Bowel Syndrome Consumption Value by Region
2.2.1 World Drugs for Irritable Bowel Syndrome Consumption Value by Region (2018-2023)
2.2.2 World Drugs for Irritable Bowel Syndrome Consumption Value Forecast by Region (2024-2029)
2.3 United States Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.4 China Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.5 Europe Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.6 Japan Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.7 South Korea Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.8 ASEAN Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.9 India Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
3 WORLD DRUGS FOR IRRITABLE BOWEL SYNDROME COMPANIES COMPETITIVE ANALYSIS
3.1 World Drugs for Irritable Bowel Syndrome Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Drugs for Irritable Bowel Syndrome Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Drugs for Irritable Bowel Syndrome in 2022
3.2.3 Global Concentration Ratios (CR8) for Drugs for Irritable Bowel Syndrome in 2022
3.3 Drugs for Irritable Bowel Syndrome Company Evaluation Quadrant
3.4 Drugs for Irritable Bowel Syndrome Market: Overall Company Footprint Analysis
3.4.1 Drugs for Irritable Bowel Syndrome Market: Region Footprint
3.4.2 Drugs for Irritable Bowel Syndrome Market: Company Product Type Footprint
3.4.3 Drugs for Irritable Bowel Syndrome Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Drugs for Irritable Bowel Syndrome Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Drugs for Irritable Bowel Syndrome Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Drugs for Irritable Bowel Syndrome Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Drugs for Irritable Bowel Syndrome Consumption Value Comparison
4.2.1 United States VS China: Drugs for Irritable Bowel Syndrome Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Drugs for Irritable Bowel Syndrome Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Drugs for Irritable Bowel Syndrome Companies and Market Share, 2018-2023
4.3.1 United States Based Drugs for Irritable Bowel Syndrome Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Drugs for Irritable Bowel Syndrome Revenue, (2018-2023)
4.4 China Based Companies Drugs for Irritable Bowel Syndrome Revenue and Market Share, 2018-2023
4.4.1 China Based Drugs for Irritable Bowel Syndrome Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Drugs for Irritable Bowel Syndrome Revenue, (2018-2023)
4.5 Rest of World Based Drugs for Irritable Bowel Syndrome Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Drugs for Irritable Bowel Syndrome Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Drugs for Irritable Bowel Syndrome Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Drugs for Irritable Bowel Syndrome Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Alosetron
5.2.2 Lubiprostone
5.2.3 Linaclotide
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2023)
5.3.2 World Drugs for Irritable Bowel Syndrome Market Size by Type (2024-2029)
5.3.3 World Drugs for Irritable Bowel Syndrome Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Drugs for Irritable Bowel Syndrome Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2023)
6.3.2 World Drugs for Irritable Bowel Syndrome Market Size by Application (2024-2029)
6.3.3 World Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Takeda Pharmaceutical Company Limited
7.1.1 Takeda Pharmaceutical Company Limited Details
7.1.2 Takeda Pharmaceutical Company Limited Major Business
7.1.3 Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Product and Services
7.1.4 Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7.1.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.2 Pfizer, Inc.
7.2.1 Pfizer, Inc. Details
7.2.2 Pfizer, Inc. Major Business
7.2.3 Pfizer, Inc. Drugs for Irritable Bowel Syndrome Product and Services
7.2.4 Pfizer, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer, Inc. Recent Developments/Updates
7.2.6 Pfizer, Inc. Competitive Strengths & Weaknesses
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Details
7.3.2 Abbott Laboratories Major Business
7.3.3 Abbott Laboratories Drugs for Irritable Bowel Syndrome Product and Services
7.3.4 Abbott Laboratories Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Abbott Laboratories Recent Developments/Updates
7.3.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.4 Novartis AG
7.4.1 Novartis AG Details
7.4.2 Novartis AG Major Business
7.4.3 Novartis AG Drugs for Irritable Bowel Syndrome Product and Services
7.4.4 Novartis AG Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis AG Recent Developments/Updates
7.4.6 Novartis AG Competitive Strengths & Weaknesses
7.5 AstraZeneca PLC
7.5.1 AstraZeneca PLC Details
7.5.2 AstraZeneca PLC Major Business
7.5.3 AstraZeneca PLC Drugs for Irritable Bowel Syndrome Product and Services
7.5.4 AstraZeneca PLC Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 AstraZeneca PLC Recent Developments/Updates
7.5.6 AstraZeneca PLC Competitive Strengths & Weaknesses
7.6 Ironwood Pharmaceuticals Inc. and Allergan Plc
7.6.1 Ironwood Pharmaceuticals Inc. and Allergan Plc Details
7.6.2 Ironwood Pharmaceuticals Inc. and Allergan Plc Major Business
7.6.3 Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Product and Services
7.6.4 Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Ironwood Pharmaceuticals Inc. and Allergan Plc Recent Developments/Updates
7.6.6 Ironwood Pharmaceuticals Inc. and Allergan Plc Competitive Strengths & Weaknesses
7.7 Bausch Health Companies Inc.
7.7.1 Bausch Health Companies Inc. Details
7.7.2 Bausch Health Companies Inc. Major Business
7.7.3 Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Product and Services
7.7.4 Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Bausch Health Companies Inc. Recent Developments/Updates
7.7.6 Bausch Health Companies Inc. Competitive Strengths & Weaknesses
7.8 GlaxoSmithKline, Plc.
7.8.1 GlaxoSmithKline, Plc. Details
7.8.2 GlaxoSmithKline, Plc. Major Business
7.8.3 GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Product and Services
7.8.4 GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 GlaxoSmithKline, Plc. Recent Developments/Updates
7.8.6 GlaxoSmithKline, Plc. Competitive Strengths & Weaknesses
7.9 Lexicon Pharmaceuticals, Inc.
7.9.1 Lexicon Pharmaceuticals, Inc. Details
7.9.2 Lexicon Pharmaceuticals, Inc. Major Business
7.9.3 Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Product and Services
7.9.4 Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Lexicon Pharmaceuticals, Inc. Recent Developments/Updates
7.9.6 Lexicon Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.10 Sucampo Pharmaceuticals, Inc.
7.10.1 Sucampo Pharmaceuticals, Inc. Details
7.10.2 Sucampo Pharmaceuticals, Inc. Major Business
7.10.3 Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Product and Services
7.10.4 Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Sucampo Pharmaceuticals, Inc. Recent Developments/Updates
7.10.6 Sucampo Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Drugs for Irritable Bowel Syndrome Industry Chain
8.2 Drugs for Irritable Bowel Syndrome Upstream Analysis
8.3 Drugs for Irritable Bowel Syndrome Midstream Analysis
8.4 Drugs for Irritable Bowel Syndrome Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Drugs for Irritable Bowel Syndrome Introduction
1.2 World Drugs for Irritable Bowel Syndrome Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Drugs for Irritable Bowel Syndrome Total Market by Region (by Headquarter Location)
1.3.1 World Drugs for Irritable Bowel Syndrome Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.3.3 China Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.3.4 Europe Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.3.5 Japan Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.3.6 South Korea Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.3.7 ASEAN Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.3.8 India Drugs for Irritable Bowel Syndrome Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drugs for Irritable Bowel Syndrome Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drugs for Irritable Bowel Syndrome Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.2 World Drugs for Irritable Bowel Syndrome Consumption Value by Region
2.2.1 World Drugs for Irritable Bowel Syndrome Consumption Value by Region (2018-2023)
2.2.2 World Drugs for Irritable Bowel Syndrome Consumption Value Forecast by Region (2024-2029)
2.3 United States Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.4 China Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.5 Europe Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.6 Japan Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.7 South Korea Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.8 ASEAN Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
2.9 India Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029)
3 WORLD DRUGS FOR IRRITABLE BOWEL SYNDROME COMPANIES COMPETITIVE ANALYSIS
3.1 World Drugs for Irritable Bowel Syndrome Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Drugs for Irritable Bowel Syndrome Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Drugs for Irritable Bowel Syndrome in 2022
3.2.3 Global Concentration Ratios (CR8) for Drugs for Irritable Bowel Syndrome in 2022
3.3 Drugs for Irritable Bowel Syndrome Company Evaluation Quadrant
3.4 Drugs for Irritable Bowel Syndrome Market: Overall Company Footprint Analysis
3.4.1 Drugs for Irritable Bowel Syndrome Market: Region Footprint
3.4.2 Drugs for Irritable Bowel Syndrome Market: Company Product Type Footprint
3.4.3 Drugs for Irritable Bowel Syndrome Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Drugs for Irritable Bowel Syndrome Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Drugs for Irritable Bowel Syndrome Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Drugs for Irritable Bowel Syndrome Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Drugs for Irritable Bowel Syndrome Consumption Value Comparison
4.2.1 United States VS China: Drugs for Irritable Bowel Syndrome Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Drugs for Irritable Bowel Syndrome Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Drugs for Irritable Bowel Syndrome Companies and Market Share, 2018-2023
4.3.1 United States Based Drugs for Irritable Bowel Syndrome Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Drugs for Irritable Bowel Syndrome Revenue, (2018-2023)
4.4 China Based Companies Drugs for Irritable Bowel Syndrome Revenue and Market Share, 2018-2023
4.4.1 China Based Drugs for Irritable Bowel Syndrome Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Drugs for Irritable Bowel Syndrome Revenue, (2018-2023)
4.5 Rest of World Based Drugs for Irritable Bowel Syndrome Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Drugs for Irritable Bowel Syndrome Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Drugs for Irritable Bowel Syndrome Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Drugs for Irritable Bowel Syndrome Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Alosetron
5.2.2 Lubiprostone
5.2.3 Linaclotide
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2023)
5.3.2 World Drugs for Irritable Bowel Syndrome Market Size by Type (2024-2029)
5.3.3 World Drugs for Irritable Bowel Syndrome Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Drugs for Irritable Bowel Syndrome Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2023)
6.3.2 World Drugs for Irritable Bowel Syndrome Market Size by Application (2024-2029)
6.3.3 World Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Takeda Pharmaceutical Company Limited
7.1.1 Takeda Pharmaceutical Company Limited Details
7.1.2 Takeda Pharmaceutical Company Limited Major Business
7.1.3 Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Product and Services
7.1.4 Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7.1.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
7.2 Pfizer, Inc.
7.2.1 Pfizer, Inc. Details
7.2.2 Pfizer, Inc. Major Business
7.2.3 Pfizer, Inc. Drugs for Irritable Bowel Syndrome Product and Services
7.2.4 Pfizer, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer, Inc. Recent Developments/Updates
7.2.6 Pfizer, Inc. Competitive Strengths & Weaknesses
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Details
7.3.2 Abbott Laboratories Major Business
7.3.3 Abbott Laboratories Drugs for Irritable Bowel Syndrome Product and Services
7.3.4 Abbott Laboratories Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Abbott Laboratories Recent Developments/Updates
7.3.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.4 Novartis AG
7.4.1 Novartis AG Details
7.4.2 Novartis AG Major Business
7.4.3 Novartis AG Drugs for Irritable Bowel Syndrome Product and Services
7.4.4 Novartis AG Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis AG Recent Developments/Updates
7.4.6 Novartis AG Competitive Strengths & Weaknesses
7.5 AstraZeneca PLC
7.5.1 AstraZeneca PLC Details
7.5.2 AstraZeneca PLC Major Business
7.5.3 AstraZeneca PLC Drugs for Irritable Bowel Syndrome Product and Services
7.5.4 AstraZeneca PLC Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 AstraZeneca PLC Recent Developments/Updates
7.5.6 AstraZeneca PLC Competitive Strengths & Weaknesses
7.6 Ironwood Pharmaceuticals Inc. and Allergan Plc
7.6.1 Ironwood Pharmaceuticals Inc. and Allergan Plc Details
7.6.2 Ironwood Pharmaceuticals Inc. and Allergan Plc Major Business
7.6.3 Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Product and Services
7.6.4 Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Ironwood Pharmaceuticals Inc. and Allergan Plc Recent Developments/Updates
7.6.6 Ironwood Pharmaceuticals Inc. and Allergan Plc Competitive Strengths & Weaknesses
7.7 Bausch Health Companies Inc.
7.7.1 Bausch Health Companies Inc. Details
7.7.2 Bausch Health Companies Inc. Major Business
7.7.3 Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Product and Services
7.7.4 Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Bausch Health Companies Inc. Recent Developments/Updates
7.7.6 Bausch Health Companies Inc. Competitive Strengths & Weaknesses
7.8 GlaxoSmithKline, Plc.
7.8.1 GlaxoSmithKline, Plc. Details
7.8.2 GlaxoSmithKline, Plc. Major Business
7.8.3 GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Product and Services
7.8.4 GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 GlaxoSmithKline, Plc. Recent Developments/Updates
7.8.6 GlaxoSmithKline, Plc. Competitive Strengths & Weaknesses
7.9 Lexicon Pharmaceuticals, Inc.
7.9.1 Lexicon Pharmaceuticals, Inc. Details
7.9.2 Lexicon Pharmaceuticals, Inc. Major Business
7.9.3 Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Product and Services
7.9.4 Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Lexicon Pharmaceuticals, Inc. Recent Developments/Updates
7.9.6 Lexicon Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.10 Sucampo Pharmaceuticals, Inc.
7.10.1 Sucampo Pharmaceuticals, Inc. Details
7.10.2 Sucampo Pharmaceuticals, Inc. Major Business
7.10.3 Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Product and Services
7.10.4 Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Sucampo Pharmaceuticals, Inc. Recent Developments/Updates
7.10.6 Sucampo Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Drugs for Irritable Bowel Syndrome Industry Chain
8.2 Drugs for Irritable Bowel Syndrome Upstream Analysis
8.3 Drugs for Irritable Bowel Syndrome Midstream Analysis
8.4 Drugs for Irritable Bowel Syndrome Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Drugs for Irritable Bowel Syndrome Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Drugs for Irritable Bowel Syndrome Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Drugs for Irritable Bowel Syndrome Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Drugs for Irritable Bowel Syndrome Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Drugs for Irritable Bowel Syndrome Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Drugs for Irritable Bowel Syndrome Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Drugs for Irritable Bowel Syndrome Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Drugs for Irritable Bowel Syndrome Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Drugs for Irritable Bowel Syndrome Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Drugs for Irritable Bowel Syndrome Players in 2022
Table 12. World Drugs for Irritable Bowel Syndrome Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Drugs for Irritable Bowel Syndrome Company Evaluation Quadrant
Table 14. Head Office of Key Drugs for Irritable Bowel Syndrome Player
Table 15. Drugs for Irritable Bowel Syndrome Market: Company Product Type Footprint
Table 16. Drugs for Irritable Bowel Syndrome Market: Company Product Application Footprint
Table 17. Drugs for Irritable Bowel Syndrome Mergers & Acquisitions Activity
Table 18. United States VS China Drugs for Irritable Bowel Syndrome Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Drugs for Irritable Bowel Syndrome Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Drugs for Irritable Bowel Syndrome Companies, Headquarters (States, Country)
Table 21. United States Based Companies Drugs for Irritable Bowel Syndrome Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Drugs for Irritable Bowel Syndrome Revenue Market Share (2018-2023)
Table 23. China Based Drugs for Irritable Bowel Syndrome Companies, Headquarters (Province, Country)
Table 24. China Based Companies Drugs for Irritable Bowel Syndrome Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Drugs for Irritable Bowel Syndrome Revenue Market Share (2018-2023)
Table 26. Rest of World Based Drugs for Irritable Bowel Syndrome Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Drugs for Irritable Bowel Syndrome Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Drugs for Irritable Bowel Syndrome Revenue Market Share (2018-2023)
Table 29. World Drugs for Irritable Bowel Syndrome Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2023) & (USD Million)
Table 31. World Drugs for Irritable Bowel Syndrome Market Size by Type (2024-2029) & (USD Million)
Table 32. World Drugs for Irritable Bowel Syndrome Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2023) & (USD Million)
Table 34. World Drugs for Irritable Bowel Syndrome Market Size by Application (2024-2029) & (USD Million)
Table 35. Takeda Pharmaceutical Company Limited Basic Information, Area Served and Competitors
Table 36. Takeda Pharmaceutical Company Limited Major Business
Table 37. Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Product and Services
Table 38. Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 40. Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 41. Pfizer, Inc. Basic Information, Area Served and Competitors
Table 42. Pfizer, Inc. Major Business
Table 43. Pfizer, Inc. Drugs for Irritable Bowel Syndrome Product and Services
Table 44. Pfizer, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Pfizer, Inc. Recent Developments/Updates
Table 46. Pfizer, Inc. Competitive Strengths & Weaknesses
Table 47. Abbott Laboratories Basic Information, Area Served and Competitors
Table 48. Abbott Laboratories Major Business
Table 49. Abbott Laboratories Drugs for Irritable Bowel Syndrome Product and Services
Table 50. Abbott Laboratories Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Abbott Laboratories Recent Developments/Updates
Table 52. Abbott Laboratories Competitive Strengths & Weaknesses
Table 53. Novartis AG Basic Information, Area Served and Competitors
Table 54. Novartis AG Major Business
Table 55. Novartis AG Drugs for Irritable Bowel Syndrome Product and Services
Table 56. Novartis AG Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novartis AG Recent Developments/Updates
Table 58. Novartis AG Competitive Strengths & Weaknesses
Table 59. AstraZeneca PLC Basic Information, Area Served and Competitors
Table 60. AstraZeneca PLC Major Business
Table 61. AstraZeneca PLC Drugs for Irritable Bowel Syndrome Product and Services
Table 62. AstraZeneca PLC Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. AstraZeneca PLC Recent Developments/Updates
Table 64. AstraZeneca PLC Competitive Strengths & Weaknesses
Table 65. Ironwood Pharmaceuticals Inc. and Allergan Plc Basic Information, Area Served and Competitors
Table 66. Ironwood Pharmaceuticals Inc. and Allergan Plc Major Business
Table 67. Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Product and Services
Table 68. Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Ironwood Pharmaceuticals Inc. and Allergan Plc Recent Developments/Updates
Table 70. Ironwood Pharmaceuticals Inc. and Allergan Plc Competitive Strengths & Weaknesses
Table 71. Bausch Health Companies Inc. Basic Information, Area Served and Competitors
Table 72. Bausch Health Companies Inc. Major Business
Table 73. Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Product and Services
Table 74. Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Bausch Health Companies Inc. Recent Developments/Updates
Table 76. Bausch Health Companies Inc. Competitive Strengths & Weaknesses
Table 77. GlaxoSmithKline, Plc. Basic Information, Area Served and Competitors
Table 78. GlaxoSmithKline, Plc. Major Business
Table 79. GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Product and Services
Table 80. GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. GlaxoSmithKline, Plc. Recent Developments/Updates
Table 82. GlaxoSmithKline, Plc. Competitive Strengths & Weaknesses
Table 83. Lexicon Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 84. Lexicon Pharmaceuticals, Inc. Major Business
Table 85. Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Product and Services
Table 86. Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Lexicon Pharmaceuticals, Inc. Recent Developments/Updates
Table 88. Sucampo Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 89. Sucampo Pharmaceuticals, Inc. Major Business
Table 90. Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Product and Services
Table 91. Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Drugs for Irritable Bowel Syndrome Upstream (Raw Materials)
Table 93. Drugs for Irritable Bowel Syndrome Typical Customers
Table 1. World Drugs for Irritable Bowel Syndrome Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Drugs for Irritable Bowel Syndrome Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Drugs for Irritable Bowel Syndrome Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Drugs for Irritable Bowel Syndrome Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Drugs for Irritable Bowel Syndrome Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Drugs for Irritable Bowel Syndrome Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Drugs for Irritable Bowel Syndrome Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Drugs for Irritable Bowel Syndrome Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Drugs for Irritable Bowel Syndrome Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Drugs for Irritable Bowel Syndrome Players in 2022
Table 12. World Drugs for Irritable Bowel Syndrome Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Drugs for Irritable Bowel Syndrome Company Evaluation Quadrant
Table 14. Head Office of Key Drugs for Irritable Bowel Syndrome Player
Table 15. Drugs for Irritable Bowel Syndrome Market: Company Product Type Footprint
Table 16. Drugs for Irritable Bowel Syndrome Market: Company Product Application Footprint
Table 17. Drugs for Irritable Bowel Syndrome Mergers & Acquisitions Activity
Table 18. United States VS China Drugs for Irritable Bowel Syndrome Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Drugs for Irritable Bowel Syndrome Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Drugs for Irritable Bowel Syndrome Companies, Headquarters (States, Country)
Table 21. United States Based Companies Drugs for Irritable Bowel Syndrome Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Drugs for Irritable Bowel Syndrome Revenue Market Share (2018-2023)
Table 23. China Based Drugs for Irritable Bowel Syndrome Companies, Headquarters (Province, Country)
Table 24. China Based Companies Drugs for Irritable Bowel Syndrome Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Drugs for Irritable Bowel Syndrome Revenue Market Share (2018-2023)
Table 26. Rest of World Based Drugs for Irritable Bowel Syndrome Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Drugs for Irritable Bowel Syndrome Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Drugs for Irritable Bowel Syndrome Revenue Market Share (2018-2023)
Table 29. World Drugs for Irritable Bowel Syndrome Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Drugs for Irritable Bowel Syndrome Market Size by Type (2018-2023) & (USD Million)
Table 31. World Drugs for Irritable Bowel Syndrome Market Size by Type (2024-2029) & (USD Million)
Table 32. World Drugs for Irritable Bowel Syndrome Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Drugs for Irritable Bowel Syndrome Market Size by Application (2018-2023) & (USD Million)
Table 34. World Drugs for Irritable Bowel Syndrome Market Size by Application (2024-2029) & (USD Million)
Table 35. Takeda Pharmaceutical Company Limited Basic Information, Area Served and Competitors
Table 36. Takeda Pharmaceutical Company Limited Major Business
Table 37. Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Product and Services
Table 38. Takeda Pharmaceutical Company Limited Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 40. Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 41. Pfizer, Inc. Basic Information, Area Served and Competitors
Table 42. Pfizer, Inc. Major Business
Table 43. Pfizer, Inc. Drugs for Irritable Bowel Syndrome Product and Services
Table 44. Pfizer, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Pfizer, Inc. Recent Developments/Updates
Table 46. Pfizer, Inc. Competitive Strengths & Weaknesses
Table 47. Abbott Laboratories Basic Information, Area Served and Competitors
Table 48. Abbott Laboratories Major Business
Table 49. Abbott Laboratories Drugs for Irritable Bowel Syndrome Product and Services
Table 50. Abbott Laboratories Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Abbott Laboratories Recent Developments/Updates
Table 52. Abbott Laboratories Competitive Strengths & Weaknesses
Table 53. Novartis AG Basic Information, Area Served and Competitors
Table 54. Novartis AG Major Business
Table 55. Novartis AG Drugs for Irritable Bowel Syndrome Product and Services
Table 56. Novartis AG Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novartis AG Recent Developments/Updates
Table 58. Novartis AG Competitive Strengths & Weaknesses
Table 59. AstraZeneca PLC Basic Information, Area Served and Competitors
Table 60. AstraZeneca PLC Major Business
Table 61. AstraZeneca PLC Drugs for Irritable Bowel Syndrome Product and Services
Table 62. AstraZeneca PLC Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. AstraZeneca PLC Recent Developments/Updates
Table 64. AstraZeneca PLC Competitive Strengths & Weaknesses
Table 65. Ironwood Pharmaceuticals Inc. and Allergan Plc Basic Information, Area Served and Competitors
Table 66. Ironwood Pharmaceuticals Inc. and Allergan Plc Major Business
Table 67. Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Product and Services
Table 68. Ironwood Pharmaceuticals Inc. and Allergan Plc Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Ironwood Pharmaceuticals Inc. and Allergan Plc Recent Developments/Updates
Table 70. Ironwood Pharmaceuticals Inc. and Allergan Plc Competitive Strengths & Weaknesses
Table 71. Bausch Health Companies Inc. Basic Information, Area Served and Competitors
Table 72. Bausch Health Companies Inc. Major Business
Table 73. Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Product and Services
Table 74. Bausch Health Companies Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Bausch Health Companies Inc. Recent Developments/Updates
Table 76. Bausch Health Companies Inc. Competitive Strengths & Weaknesses
Table 77. GlaxoSmithKline, Plc. Basic Information, Area Served and Competitors
Table 78. GlaxoSmithKline, Plc. Major Business
Table 79. GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Product and Services
Table 80. GlaxoSmithKline, Plc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. GlaxoSmithKline, Plc. Recent Developments/Updates
Table 82. GlaxoSmithKline, Plc. Competitive Strengths & Weaknesses
Table 83. Lexicon Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 84. Lexicon Pharmaceuticals, Inc. Major Business
Table 85. Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Product and Services
Table 86. Lexicon Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Lexicon Pharmaceuticals, Inc. Recent Developments/Updates
Table 88. Sucampo Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 89. Sucampo Pharmaceuticals, Inc. Major Business
Table 90. Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Product and Services
Table 91. Sucampo Pharmaceuticals, Inc. Drugs for Irritable Bowel Syndrome Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Drugs for Irritable Bowel Syndrome Upstream (Raw Materials)
Table 93. Drugs for Irritable Bowel Syndrome Typical Customers
LIST OF FIGURES
Figure 1. Drugs for Irritable Bowel Syndrome Picture
Figure 2. World Drugs for Irritable Bowel Syndrome Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Drugs for Irritable Bowel Syndrome Total Market Size (2018-2029) & (USD Million)
Figure 4. World Drugs for Irritable Bowel Syndrome Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Drugs for Irritable Bowel Syndrome Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 13. Drugs for Irritable Bowel Syndrome Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 16. World Drugs for Irritable Bowel Syndrome Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 18. China Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 23. India Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Drugs for Irritable Bowel Syndrome by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Drugs for Irritable Bowel Syndrome Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Drugs for Irritable Bowel Syndrome Markets in 2022
Figure 27. United States VS China: Drugs for Irritable Bowel Syndrome Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Drugs for Irritable Bowel Syndrome Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Drugs for Irritable Bowel Syndrome Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Drugs for Irritable Bowel Syndrome Market Size Market Share by Type in 2022
Figure 31. Alosetron
Figure 32. Lubiprostone
Figure 33. Linaclotide
Figure 34. Others
Figure 35. World Drugs for Irritable Bowel Syndrome Market Size Market Share by Type (2018-2029)
Figure 36. World Drugs for Irritable Bowel Syndrome Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Drugs for Irritable Bowel Syndrome Market Size Market Share by Application in 2022
Figure 38. Hospital
Figure 39. Clinic
Figure 40. Others
Figure 41. Drugs for Irritable Bowel Syndrome Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. Drugs for Irritable Bowel Syndrome Picture
Figure 2. World Drugs for Irritable Bowel Syndrome Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Drugs for Irritable Bowel Syndrome Total Market Size (2018-2029) & (USD Million)
Figure 4. World Drugs for Irritable Bowel Syndrome Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Drugs for Irritable Bowel Syndrome Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Drugs for Irritable Bowel Syndrome Revenue (2018-2029) & (USD Million)
Figure 13. Drugs for Irritable Bowel Syndrome Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 16. World Drugs for Irritable Bowel Syndrome Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 18. China Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 23. India Drugs for Irritable Bowel Syndrome Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Drugs for Irritable Bowel Syndrome by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Drugs for Irritable Bowel Syndrome Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Drugs for Irritable Bowel Syndrome Markets in 2022
Figure 27. United States VS China: Drugs for Irritable Bowel Syndrome Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Drugs for Irritable Bowel Syndrome Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Drugs for Irritable Bowel Syndrome Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Drugs for Irritable Bowel Syndrome Market Size Market Share by Type in 2022
Figure 31. Alosetron
Figure 32. Lubiprostone
Figure 33. Linaclotide
Figure 34. Others
Figure 35. World Drugs for Irritable Bowel Syndrome Market Size Market Share by Type (2018-2029)
Figure 36. World Drugs for Irritable Bowel Syndrome Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Drugs for Irritable Bowel Syndrome Market Size Market Share by Application in 2022
Figure 38. Hospital
Figure 39. Clinic
Figure 40. Others
Figure 41. Drugs for Irritable Bowel Syndrome Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
